The Biomedical Innovation Program at OHSU accelerates the delivery of healthcare technologies in order to improve human health. The program cultivates, evaluates and funds promising translational projects with the objective of moving innovative technologies to clinical application through commercialization. Review program services in the diagram above or read about program services in this pdf.
Do you have an idea for a technical innovation to improve human health? See the funding opportunities below, choose your focus, and let us hear from you.
BIP funding opportunities
This funding opportunity is intended for medical device and diagnostic technology projects. Through this funding mechanism, OCTRI and TTBD intend to support and accelerate creative, interdisciplinary device and diagnostic development research at OHSU. Projects will typically be supported for a one-year period. Predetermined milestones and quantitative metrics of success will be evaluated on a regular basis.
Deadline: Letter of Intent (LOI) due 9/23/20 by 11:59pm
Amount: Up to $40,000
Eligibility: Principal Investigators must meet the OHSU eligibility requirements
This funding opportunity is intended for drug discovery platforms and therapeutic technology projects. Examples of responsive application topics include, but are not limited to: development and validation of drug targets, screening platforms, small molecules, antibodies, vaccines and biologics. Through this funding mechanism, OCTRI and TTBD intend to support and accelerate creative, interdisciplinary drug discovery and therapeutic development research at OHSU. Projects will typically be supported for a one-year period. Predetermined milestones and quantitative metrics of success will be evaluated on a regular basis.
Deadline: Midnight on May 28th, 2020
Amount: Up to $60,000
Eligibility: Principal Investigators must meet the OHSU eligibility requirements.
The 2020 Biomedical Innovation Program Drug Discovery RFA has details about the submission process, eligibility and application instructions.
This new track of funding is intended to support novel and innovative ideas that use digital technology to improve healthcare delivery or advance biomedical research with the potential for commercialization, achieving cost savings, improving research efficiency, improving quality of patient care, and/or reducing provider burnout.
Grants will be awarded on a competitive basis, with budgets not to exceed $30,000. Additionally, each awardee will be assigned a project manager and a mentor to advise and help accelerate their project towards commercialization. Projects will typically be supported for a 6-month period; predetermined milestones and quantitative metrics of success will be evaluated on a regular basis.
Deadline: Letter of intent due February 20, 2020. See all key dates in RFA below.
Amount: Up to $30,000
Eligibility: OHSU employees and students. Restrictions apply - see RFA for details.
The 2020 Biomedical Innovation Program Digital Health RFA has details about the submission process, eligibility and application instructions.
OHSU Research & Innovation, in partnership with The Oregon Clinical & Translational Research Institute (OCTRI), OHSU Technology Transfer and OHSU Collaborations and Entrepreneurship, are accepting proposals for basic or clinical research across the translational spectrum that directly addresses COVID-19 from all disciplines.
Amount: Up to $75,000
Eligibility: Applicants must meet OHSU Principal Investigator requirements.
BIP application resources
Need help preparing your BIP application? Check out these vetted resources. Please note: the links and resources provided below are not meant to comprehensive, but rather to give applicants an introduction to concepts and terminology which may be unfamiliar.
There are numerous online marketing and commercialization (introducing a new product or service into the market) resources. The following websites provide well-curated, concise articles and videos covering topics that are generally suited for beginners to the commercialization process.
Value Proposition and the business model canvas
Creating a value proposition and populating a business model canvas allows you to identify the problem and solution, determine who will benefit, and predict the value of the proposed technology over existing solutions.
Marketing and stakeholder analyses help identify key competition, opportunities, potential investors, and the economic environment within your innovation’s specific industry.
Intellectual property protects original ideas and innovations typically through copyrights, patents, trademarks, and trade secrets. OHSU Technology Transfer has highly-trained Patent Associates and Technology Development Managers who are available to help you navigate the complex intellectual property environment.
Depending on the innovation, specific regulatory pathways must be followed to ensure adherence to federal guidelines (e.g. FDA). Inventors should have a general understanding of the regulatory compliance requirements related to their innovation.
- Regulatory Basics from the Stanford Biodesign program (video)
Elevator pitch and pitch deck
Developing effective elevator pitches and slide decks are essential tools for promoting your technology and attracting investors in a concise, clear, and engaging manner.
Identifying clear, yet diverse commercialization pathways is important for the success of a potential technology, whether it be determining licensing potential, startup opportunities, or pursuing adequate intellectual property protections to ensure maximum success.
- From Lab to Market: Pitt Commercialization Process (website)
A non-confidential summary (NCS) serves as a technology advertisement to attract potential licensees, investors, or other business partners without compromising key intellectual property.
- Non-Confidential summary example and template (pdf)
- Tips from OHSU Technology Transfer on crafting an NCS (pdf)
Thinking of forming a start-up company? OHSU Collaborations & Entrepreneurship - New Ventures has you covered.
Phase 0 program (SBIR/STTR application support)
Business Oregon and OCTRI are helping Oregon small businesses access federal funding through successful Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications. Here’s what you need to know:
The Biomedical Innovation Program is a partnership between OCTRI, OHSU Technology Transfer, and OHSU Collaboration and Entrepreneurship. Additional funding for the program has been provided by:
Learn more about resources in OHSU Technology Transfer that can help you commercialize your research.
Meet our awardees
Hear from Biomedical Innovation Program awardees—in their own words.
Need proof-of-concept or user experience data for your mobile app idea?
The Mobile Apps for Clinical Studies (MACS) program may be able to help.
Looking for more opportunities?
Check out our Innovation and Entrepreneur Education web page.